Emerging studies suggest that neuroendocrine and hypothalamic changes in HD may 1) cause symptoms and signs such as anxiety, depression and metabolic disturbances, 2) provide biomarkers to track disease progression and severity, and 3) be involved in the pathogenic disease process.